Delivery Order SPE2DB22D1202-SPE2DB24FUUB4
Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,353.06 firm fixed-price delivery order is for the supply of HYSINGLA ER 40 MG TABLET 60S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of 4568732359 - HYSINGLA ER 40 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,314.08. The contract is a firm fixed price delivery order with a completion date of July 9, 2025. Amerisourcebergen Drug Corp is registered in the System for Award Management (SAM) and is designated as a...
- This federal contract award, valued at $7,177.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hysingla ER 30 mg tablets, a medication used for pain management. This contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 80 mg Hysingla ER tablets, with a ceiling value of $1,531.57. The contract, which is not set-aside and employs firm fixed-price terms, was awarded on December 31, 2025, with an ultimate completion date of January 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- This federal contract award, identified as SPE2DX15D3306|SPE2DX24FAEVF, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of HYSINGLA ER 20 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,382.62 and a period of performance through April 2, 2024. This delivery order contract is a firm fixed price arrangement, with no set-aside designation used....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,887.98 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Hysingla ER 20 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,286.49 to AmerisourceBergen Drug Corp for the supply of HYSINGLA ER 20 mg tablets (60-count units) on January 28, 2026. This firm fixed-price contract, which is not set-aside, was completed by January 29, 2026, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HYSINGLA ER 20 mg tablets (60-count) valued at $1,327.16 under a firm fixed-price contract. The award was issued on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement from AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, for the supply of Hysingla ER 20 mg tablets (60-count packages) under a firm fixed-price contract valued at $1,066.00. The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,182.07 to AmerisourceBergen Drug Corp for Hysingla ER 40 mg tablets (60-count package) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Hysingla ER is an extended-release opioid analgesic used for chronic pain...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUUB4Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation and a leading global pharmaceutical distributor. The contract, valued at $1,163.38, is for the delivery of HYSINGLA ER 60 MG TABLET 60S, a specialty pharmaceutical product. This order falls under a larger $999,999,999.00 indefinite delivery contract that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. No set-aside designations were used for this contract award.
Generated 6/17/24, 9:15 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/18/24 |